The Hindu – Business Line
http://www.thehindubusinessline.com/
After $1 diarrhoea vaccine, Govt wants same for malaria, TB
A. M. Jigeesh
Partnership with industry helps pool research abilities, expertise
New Delhi, May 16:
Excerpt
Buoyed by the success of the public Private partnership experiment in developing the first indigenous rotavirus vaccine to combat a deadly form of viral diarrhoea, the Department of Biotechnology will now shift its focus to researching vaccines for dengue, tuberculosis and malaria.
Maintaining that affordability is the Government’s main mantra, the Department is ready to co-operate with the pharmaceutical industry to make vaccines that prevent killer diseases.
Dr T.S. Rao, who heads the vaccines and diagnostics section of the Department, told Business Line that an inter-ministerial group has been formed to help the Rotavac, the one-dollar rotavirus vaccine, to get the necessary policy clearances…
vaccines and global health :: ethics and policy 